M Teresa Villanueva
M Teresa Villanueva
Kritika Chaudhari
Kritika Chaudhari
Analysis of a decade of post-authorisation studies for medicines approved by the EMA [0.03%]
EMA批准药物的药后十年审批评估分析研究摘要
Caroline Voltz-Girolt,Guillem Wetherell Mateu,Carla Torre et al.
Caroline Voltz-Girolt et al.
Katie Kingwell
Katie Kingwell
Reply to 'Stimulating medicines repurposing in the EU: a pilot project' [0.03%]
对“刺激欧盟医药再利用：一个试点项目”的回复
Pan Pantziarka,Patricia Vandamme,Alicia Soler et al.
Pan Pantziarka et al.
Alex Eccleston
Alex Eccleston
Therapeutic and prophylactic strategies for Ebola caused by Bundibugyo virus [0.03%]
布迪博焦埃博拉病毒病的治疗和预防策略
Jean B Nachega,Jean-Jacques Muyembe-Tamfum,Alimuddin Zumla
Jean B Nachega
Kenneth R Chien,Kylie S Foo,Nevin Witman
Kenneth R Chien
mRNA technology, which has enabled the rapid development of vaccines for infectious diseases, also holds great promise for a new generation of therapies for a host of rare and common diseases. A decade of clinical trials are beginning to cl...
Sarah Crunkhorn
Sarah Crunkhorn
Sarah Crunkhorn
Sarah Crunkhorn